Compare GIFI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIFI | CATX |
|---|---|---|
| Founded | 1985 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.0M | 211.1M |
| IPO Year | 1997 | N/A |
| Metric | GIFI | CATX |
|---|---|---|
| Price | $11.96 | $2.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.56 |
| AVG Volume (30 Days) | 169.0K | ★ 1.3M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $166,767,000.00 | $1,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.66 | ★ N/A |
| Revenue Growth | ★ 0.26 | N/A |
| 52 Week Low | $5.75 | $1.60 |
| 52 Week High | $12.00 | $5.39 |
| Indicator | GIFI | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 87.10 | 54.24 |
| Support Level | $11.92 | $2.67 |
| Resistance Level | $11.98 | $2.82 |
| Average True Range (ATR) | 0.02 | 0.18 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 55.56 | 68.89 |
Gulf Island Fabrication Inc is a U.S. based company that is a fabricator of complex steel structures and marine vessels. The company also provides installation, hook-up, commissioning, repair, and maintenance services with specialized crews. The company operates through segments namely Fabrication division which fabricates structures such as offshore drilling and production platforms and other steel structures for customers in the oil and gas industries; the Shipyards division manufactures newly built and repairs various steel marine vessels in the United States; the Services division provides interconnect piping services on offshore platforms, welding, and inshore structures and also provides maintenance and industrial facilities. Majority revenue is from services segment.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.